Bolt Biotherapeutics, Inc.
BOLT
$4.28
$0.081.79%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -16.77% | -13.80% | -8.22% | -10.48% | -17.93% |
| Total Receivables | -98.46% | 2.64% | 848.00% | -85.92% | -39.06% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 87.99% | -28.36% | -26.80% | 23.24% | 46.40% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -46.67% | -52.17% | 0.00% | 0.00% | -6.56% |
| Total Current Assets | -14.90% | -15.01% | -7.12% | -9.82% | -16.34% |
|
|
|||||
| Total Current Assets | -14.90% | -15.01% | -7.12% | -9.82% | -16.34% |
| Net Property, Plant & Equipment | -4.24% | -4.24% | -3.84% | -4.18% | -6.78% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.55% | 44.48% | -3.57% | 16.57% | -1.05% |
| Total Assets | -15.37% | -12.77% | -13.84% | -12.07% | -13.82% |
|
|
|||||
| Total Accounts Payable | 20.30% | -4.94% | -18.03% | 20.73% | 1.79% |
| Total Accrued Expenses | -40.97% | -22.56% | -28.22% | -14.42% | -25.11% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.60% | 4.67% | 5.51% | 6.63% | 6.62% |
| Total Finance Division Other Current Liabilities | -24.90% | -37.51% | -25.17% | -24.50% | -9.99% |
| Total Other Current Liabilities | -24.90% | -37.51% | -25.17% | -24.50% | -9.99% |
| Total Current Liabilities | -12.95% | -15.36% | -19.04% | -9.23% | -14.47% |
|
|
|||||
| Total Current Liabilities | -12.95% | -15.36% | -19.04% | -9.23% | -14.47% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.87% | -3.62% | -3.40% | -3.07% | -2.83% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -9.90% | -20.08% | -22.99% | -14.40% | -12.13% |
| Total Liabilities | -6.74% | -8.22% | -10.11% | -6.13% | -7.97% |
|
|
|||||
| Common Stock & APIC | 0.11% | 0.22% | 0.08% | 0.13% | 0.15% |
| Retained Earnings | -1.57% | -1.46% | -1.60% | -1.95% | -2.58% |
| Treasury Stock & Other | 47.62% | -110.00% | -66.67% | -115.00% | -58.76% |
| Total Common Equity | -25.21% | -17.43% | -17.35% | -17.02% | -18.16% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -25.21% | -17.43% | -17.35% | -17.02% | -18.16% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -25.21% | -17.43% | -17.35% | -17.02% | -18.16% |
|
|
|||||